Tere M. Williams
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$3.8MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 17, 2026 | NIH | SBIR Phase II A novel siRNA therapeutic to prevent scarring and bleb failure after trabeculectomy | $1.0M | DUB THERAPEUTICS INC. |
| Sep 5, 2025 | NIH | SBIR Phase II A novel siRNA therapeutic to prevent scarring and bleb failure after trabeculectomy | $1.0M | DUB THERAPEUTICS INC. |
| Sep 11, 2024 | NIH | SBIR Phase II A single dose anti-scarring therapeutic for the cornea | $182K | DUB THERAPEUTICS INC. |
| Aug 20, 2024 | NIH | SBIR Phase II A single dose anti-scarring therapeutic for the cornea | $918K | DUB THERAPEUTICS INC. |
| Sep 19, 2023 | NIH | SBIR Phase II A single dose anti-scarring therapeutic for the cornea | $700K | DUB THERAPEUTICS INC. |
Peer ranks
Federal funding#425
Awards as PI#417
Patents#273
Companies
- DUB THERAPEUTICS INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.